Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression
Lars J S Kemp(Radboud University Nijmegen), Martijn Gloerich(University Medical Center Utrecht), Jolanda M. van Dieren(The Netherlands Cancer Institute), Rachel S. van der Post(Radboud University Nijmegen), Lodewijk A.A. Brosens(Utrecht University), Tanya M. Bisseling(Radboud University Nijmegen), Colin S. Wood(University of Glasgow), Antoine Khalil(Assistance Publique – Hôpitaux de Paris), Liudmila L. Kodach(The Netherlands Cancer Institute), Nigel B. Jamieson(University of Glasgow), Jooske L. Monster(University Medical Center Utrecht), Martijn Moers(University Medical Center Utrecht), Marjolein J. Vliem(Utrecht University)
Cited by 9
Related Papers
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
|The Lancet Oncology|2010|293